These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 10953178)

  • 1. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.
    Jack CR; Petersen RC; Xu Y; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Tangalos EG; Kokmen E
    Neurology; 2000 Aug; 55(4):484-89. PubMed ID: 10953178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
    Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
    Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
    Jack CR; Petersen RC; Xu YC; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Waring SC; Tangalos EG; Kokmen E
    Neurology; 1999 Apr; 52(7):1397-403. PubMed ID: 10227624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.
    Jack CR; Shiung MM; Weigand SD; O'Brien PC; Gunter JL; Boeve BF; Knopman DS; Smith GE; Ivnik RJ; Tangalos EG; Petersen RC
    Neurology; 2005 Oct; 65(8):1227-31. PubMed ID: 16247049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
    Liu G; Liu C; Qiu A;
    Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
    Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
    Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.
    Stoub TR; Rogalski EJ; Leurgans S; Bennett DA; deToledo-Morrell L
    Neurobiol Aging; 2010 Jul; 31(7):1089-98. PubMed ID: 18809228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
    Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
    Madusanka N; Choi HK; So JH; Choi BK; Park HG
    Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
    van de Pol LA; van der Flier WM; Korf ES; Fox NC; Barkhof F; Scheltens P
    Neurology; 2007 Oct; 69(15):1491-7. PubMed ID: 17923611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.
    Morra JH; Tu Z; Apostolova LG; Green AE; Avedissian C; Madsen SK; Parikshak N; Hua X; Toga AW; Jack CR; Schuff N; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2009 Sep; 30(9):2766-88. PubMed ID: 19172649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.
    Henneman WJ; Sluimer JD; Barnes J; van der Flier WM; Sluimer IC; Fox NC; Scheltens P; Vrenken H; Barkhof F
    Neurology; 2009 Mar; 72(11):999-1007. PubMed ID: 19289740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI.
    Wolz R; Heckemann RA; Aljabar P; Hajnal JV; Hammers A; Lötjönen J; Rueckert D;
    Neuroimage; 2010 Aug; 52(1):109-18. PubMed ID: 20382238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment.
    Becker JT; Davis SW; Hayashi KM; Meltzer CC; Toga AW; Lopez OL; Thompson PM;
    Arch Neurol; 2006 Jan; 63(1):97-101. PubMed ID: 16401741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
    Leung KK; Bartlett JW; Barnes J; Manning EN; Ourselin S; Fox NC;
    Neurology; 2013 Feb; 80(7):648-54. PubMed ID: 23303849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.